Hematology & Oncology in Cranston, RI
6 verified hematology & oncology doctors in Cranston.
Hematologist-oncologists treat blood disorders and cancers, coordinating chemotherapy and blood-related care.
NPPES tenure ≠ clinical experience. "Years on NPPES" is time since the physician first registered a National Provider Identifier, not time practicing medicine. Verify current license status with the state medical board.
Verify a license at the Rhode Island Board of Medical Licensure & Discipline
Dr. Plakyil Joseph, MD
Hematology & Oncology
CMS Open Payments· $297.35 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$297.35
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 57th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Plakyil Joseph do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Sundaresan Sambandam, MD
Hematology & Oncology
CMS Open Payments· $254.19 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$254.19
Total received
5
Transactions
4
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 56th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Sundaresan Sambandam do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Mark Robbins, MD
Hematology & Oncology
CMS Open Payments· $1,925 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$1,925
Total received
87
Transactions
40
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total ranks around the 71th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Mark Robbins do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Fatima Raza, MD
Hematology & Oncology
CMS Open Payments· No payments in 2023
Industry Payments
No industry payments on record in the 2023 CMS Open Payments data. This doctor received no reported payments from drug or device makers that year.
Dr. Ayesha Hassan, MD
Hematology & Oncology
CMS Open Payments· $120.06 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$120.06
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 49th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Ayesha Hassan do not imply any wrongdoing. Many are meals, education, or research support.
Dr. Susan Hobin, MD
Hematology & Oncology
CMS Open Payments· $90.00 (2023)
Industry Payments (2023)
Reported by drug and device makers to CMS Open Payments. These payments are legal and disclosed — shown as context, not a judgment.
$90.00
Total received
1
Transactions
1
Paying companies
Top paying companies
Among the 11,711 hematology & oncology doctors we've analyzed, about 62% received any industry payment (median $1,465 among those who did). This doctor's total is on the lower end — around the 47th percentile of that group.
Benchmark reflects doctors we've analyzed, not all US hematology & oncology doctors.
Payments to Susan Hobin do not imply any wrongdoing. Many are meals, education, or research support.